Colgate Announces 1st Quarter 2013 Results
Strong Organic Sales Growth Worldwide
Net income and Diluted earnings per share in first quarter 2013 were
Net income and Diluted earnings per share in first quarter 2012 were
Excluding the above noted items in both periods, Net income in first
quarter 2013 was
Gross profit margin was 58.3% in first quarter 2013 versus 58.0% in the
year ago quarter. Excluding the above noted items in both periods, Gross
profit margin was 58.6% in first quarter 2013, an increase of 40 basis
points versus the year ago quarter, as higher pricing and cost savings
from the Company's funding-the-growth initiatives more than offset
higher raw and packaging material costs and the impact of the sale of
higher cost inventory on hand in
Selling, general and administrative expenses were 35.6% of Net sales in
first quarter 2013 versus 35.2% in first quarter 2012. Excluding the
above noted items in both periods, Selling, general and administrative
expenses increased by 40 basis points to 35.4% of Net sales in first
quarter 2013, as advertising investment increased by 20 basis points and
overhead expenses increased by 20 basis points primarily due to
increased investment in customer development initiatives. Worldwide
advertising investment on an absolute basis increased 5% versus the year
ago quarter to
Operating profit decreased 21% to
Net cash provided by operations increased 17% to
"The excellent 6.0% organic sales growth was well balanced between solid unit volume gains and higher pricing worldwide. All operating divisions achieved positive organic sales growth in the quarter, led by the emerging markets where organic sales grew a robust 9.5%.
"Advertising investment increased versus year ago, both absolutely and as a percent to sales, and we continue to plan for higher levels of commercial investment in the balance of the year in support of a very full pipeline of new products worldwide.
"Colgate's global market shares in toothpaste and manual toothbrushes are both at record highs year to date. Colgate's share of the global toothpaste market strengthened to 45.6% year to date, up 0.1 share points versus year ago. Our global leadership in manual toothbrushes also strengthened during the quarter with Colgate's global market share in that category reaching 33.4% year to date, up 0.4 share points versus year ago.
"Looking forward, we expect our growth momentum to continue as we progress through the year. We are pleased that our global restructuring program is on track and proceeding smoothly. We also continue to be sharply focused on our aggressive funding-the-growth programs and our strategic worldwide pricing initiatives.
"Based on this, we anticipate another year of strong organic sales
growth and gross margin expansion in 2013. In light of the ongoing
impact of the
At
The following are comments about divisional performance for first quarter 2013 versus the year ago period. See attached Geographic Sales Analysis and Segment Information schedules for additional information on divisional sales and operating profit.
North
Operating profit in
In the U.S., new product launches are contributing to volume growth across categories. Market share gains year to date were seen in manual toothbrushes, powered toothbrushes, mouthwash, body washes and fabric conditioners. In toothpaste, the success of Colgate Optic White and Colgate Optic White Dual Action toothpastes helped drive market share for the Optic White brand to 5.7% year to date, up 1.3 share points versus year ago. In manual toothbrushes, Colgate's market share reached a record 37.1% year to date, up 0.3 share points versus year ago, driven by the success of Colgate 360° Optic White, Colgate 360° Total Advanced Floss Tip bristles and Colgate Extra Clean manual toothbrushes.
Successful new products driving volume growth in the U.S. in other categories include Colgate Optic White mouthwash, Softsoap brand Acai Berry & Tropical Water and Softsoap brand Coconut Island Quench body washes, Irish Spring Deep Action Scrub bar soap, Softsoap brand Antibacterial liquid hand soap, Palmolive Lotus Blossom & Lavender and Ajax with Aloe dish liquids and Suavitel Silky Essence fabric conditioner.
Exciting new products launching in second quarter 2013 include Colgate
Total Advanced Pro-Shield mouthwash, an important addition to the
Colgate Total oral care regimen. The launch will be supported by an
integrated marketing campaign featuring television personality
Latin
Operating profit in
Colgate's strong leadership in oral care throughout
Products in other categories contributing to market share gains include Protex Men and Palmolive Naturals Pomegranate bar soaps, Speed Stick DNA and Lady Speed Stick Neutro deodorants, Axion dish liquid and the relaunch of Suavitel Good Bye Ironing fabric conditioner.
Operating profit in
Colgate strengthened its oral care leadership in the
Recent premium innovations contributing to volume growth in other
product categories include Colgate Max White One,
Operating profit in
Colgate continued its toothpaste leadership in
Successful products contributing to volume growth in other categories in the region include Colgate Slim Soft and Colgate 360° Surround manual toothbrushes, Colgate Optic White and Colgate Plax Fruity Fresh mouthwashes and Protex for Men shower gel.
Hill's Pet Nutrition (12% of Company Sales)
Hill's Net sales decreased 1.5% during first quarter 2013. Unit volume
decreased 3.0%, pricing increased 3.5% and foreign exchange was negative
2.0%. Volume declines in the U.S.,
Hill's Operating profit decreased 8% in the first quarter of 2013 to
New product introductions contributing to sales in the U.S. include Hill's Ideal Balance Canine and Feline, with natural ingredients perfectly balanced, Prescription Diet Canine and Feline Metabolic Advanced Weight Solution, Prescription Diet i/d Canine Low Fat GI Restore, specially formulated to help manage gastrointestinal disorders, and the relaunch of Science Diet Canine and Feline with upgraded meat first, 100% natural ingredients and improved package design.
New pet food products contributing to international sales include reformulated Science Plan Adult and Mature Adult Canine and Feline with improved taste, reformulated Prescription Diet j/d Canine with improved taste, Prescription Diet Canine and Feline Metabolic Advanced Weight Solution and the relaunch of Science Plan Nature's Best with upgraded ingredients and package design.
***
About
Substantially all market share data included in this press release is compiled from data as measured by Nielsen.
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast (other than historical
information) may contain forward-looking statements. Such statements may
relate, for example, to sales or volume growth, organic sales growth,
profit or profit margin growth, earnings growth, financial goals, the
impact of currency devaluations, exchange controls, price controls and
labor unrest, including in
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:
To supplement Colgate's Condensed Consolidated Income Statements
presented in accordance with accounting principles generally accepted in
This release discusses organic sales growth, which is Net sales growth
excluding the impact of foreign exchange, acquisitions and divestments.
Management believes this measure provides investors with useful
supplemental information regarding the Company's underlying sales trends
by presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions and divestments. See
"Geographic Sales Analysis Percentage Changes" for the three months
ended
The Company uses these financial measures internally in its budgeting process and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company's ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is not a GAAP
measurement and may not be comparable to similarly titled measures
reported by other companies. See "Condensed Consolidated Statements of
Cash Flows" for the three months ended
(See attached tables for first quarter results.)
Table 1 | |||||||||||
|
|||||||||||
Condensed Consolidated Statements of Income | |||||||||||
For the Three Months Ended |
|||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||
2013 | 2012 | ||||||||||
Net sales | $ | 4,315 | $ | 4,200 | |||||||
Cost of sales | 1,800 | 1,763 | |||||||||
Gross profit | 2,515 | 2,437 | |||||||||
Gross profit margin | 58.3 | % | 58.0 | % | |||||||
Selling, general and administrative expenses | 1,536 | 1,478 | |||||||||
Other expense, net | 237 | 21 | |||||||||
Operating profit | 742 | 938 | |||||||||
Operating profit margin | 17.2 | % | 22.3 | % | |||||||
Interest (income) expense, net | (3 | ) | 10 | ||||||||
Income before income taxes | 745 | 928 | |||||||||
Provision for income taxes | 239 | 295 | |||||||||
Effective tax rate | 32.1 | % | 31.8 | % | |||||||
Net income including noncontrolling interests | 506 | 633 | |||||||||
Less: Net income attributable to noncontrolling interests | 46 | 40 | |||||||||
Net income attributable to |
$ | 460 | $ | 593 | |||||||
Earnings per common share | |||||||||||
Basic | $ | 0.98 | $ | 1.24 | |||||||
Diluted | $ | 0.97 | $ | 1.23 | |||||||
Average common shares outstanding | |||||||||||
Basic | 468.3 | 480.1 | |||||||||
Diluted | 472.5 | 483.9 | |||||||||
|
Table 2 | |||||||||||||||||||
|
||||||||||||||||||||
Condensed Consolidated Balance Sheets | ||||||||||||||||||||
As of |
||||||||||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||||||||||
|
|
|
||||||||||||||||||
2013 | 2012 | 2012 | ||||||||||||||||||
Cash and cash equivalents | $ | 932 | $ | 884 | $ | 1,044 | ||||||||||||||
Receivables, net | 1,808 | 1,668 | 1,827 | |||||||||||||||||
Inventories | 1,371 | 1,365 | 1,400 | |||||||||||||||||
Other current assets | 717 | 639 | 578 | |||||||||||||||||
Property, plant and equipment, net | 3,820 | 3,842 | 3,702 | |||||||||||||||||
Other assets, including goodwill and intangibles | 4,885 | 4,996 | 4,703 | |||||||||||||||||
Total assets | $ | 13,533 | $ | 13,394 | $ | 13,254 | ||||||||||||||
Total debt | $ | 5,357 | $ | 5,230 | $ | 4,967 | ||||||||||||||
Other current liabilities | 3,829 | 3,432 | 3,735 | |||||||||||||||||
Other non-current liabilities | 2,328 | 2,342 | 2,056 | |||||||||||||||||
Total liabilities | 11,514 | 11,004 | 10,758 | |||||||||||||||||
|
1,772 | 2,189 | 2,290 | |||||||||||||||||
Noncontrolling interests | 247 | 201 | 206 | |||||||||||||||||
Total liabilities and shareholders' equity | $ | 13,533 | $ | 13,394 | $ | 13,254 | ||||||||||||||
Supplemental Balance Sheet Information | ||||||||||||||||||||
Debt less cash, cash equivalents and marketable securities* | $ | 4,261 | $ | 4,230 | $ | 3,841 | ||||||||||||||
Working capital % of sales | (0.5 | )% | 0.7 | % | (0.1 | )% | ||||||||||||||
* |
Marketable securities of |
in Other current assets. | |
Table 3 |
|||||||||||
|
|||||||||||
Condensed Consolidated Statements of Cash Flows | |||||||||||
For the Three Months Ended |
|||||||||||
(Dollars in Millions) (Unaudited) | |||||||||||
2013 | 2012 | ||||||||||
Operating Activities | |||||||||||
Net income including noncontrolling interests | $ | 506 | $ | 633 | |||||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | |||||||||||
Depreciation and amortization | 110 | 106 | |||||||||
Restructuring and termination benefits, net of cash | 30 | (17 | ) | ||||||||
Stock-based compensation expense | 32 | 29 | |||||||||
|
172 | - | |||||||||
Deferred income taxes | (17 | ) | 22 | ||||||||
Cash effects of changes in: | |||||||||||
Receivables | (175 | ) | (90 | ) | |||||||
Inventories | (15 | ) | (38 | ) | |||||||
Accounts payable and other accruals | 112 | (35 | ) | ||||||||
Other non-current assets and liabilities | 22 | 52 | |||||||||
Net cash provided by operations | 777 | 662 | |||||||||
Investing Activities | |||||||||||
Capital expenditures | (94 | ) | (60 | ) | |||||||
Purchases of marketable securities and investments | (199 | ) | (51 | ) | |||||||
Proceeds from sale of marketable securities and investments | 54 | 32 | |||||||||
Other | 7 | 38 | |||||||||
Net cash used in investing activities | (232 | ) | (41 | ) | |||||||
Financing Activities | |||||||||||
Principal payments on debt | (1,436 | ) | (1,013 | ) | |||||||
Proceeds from issuance of debt | 1,553 | 1,183 | |||||||||
Dividends paid | (290 | ) | (278 | ) | |||||||
Purchases of treasury shares | (385 | ) | (463 | ) | |||||||
Proceeds from exercise of stock options and excess tax benefits | 96 | 106 | |||||||||
Net cash used in financing activities | (462 | ) | (465 | ) | |||||||
Effect of exchange rate changes on Cash and cash equivalents | (35 | ) | 10 | ||||||||
Net increase in Cash and cash equivalents | 48 | 166 | |||||||||
Cash and cash equivalents at beginning of period | 884 | 878 | |||||||||
Cash and cash equivalents at end of period | $ | 932 | $ | 1,044 | |||||||
Supplemental Cash Flow Information | |||||||||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | |||||||||||
Net cash provided by operations | $ | 777 | $ | 662 | |||||||
Less: Capital expenditures | (94 | ) | (60 | ) | |||||||
Free cash flow before dividends | $ | 683 | $ | 602 | |||||||
Income taxes paid | $ | 182 | $ | 223 | |||||||
|
Table 4 | |||||||||||
|
||||||||||||
Segment Information | ||||||||||||
For the Three Months Ended |
||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||
Three Months Ended |
||||||||||||
2013 | 2012 | |||||||||||
Net sales | ||||||||||||
Oral, Personal and Home Care | ||||||||||||
|
$ | 764 | $ | 724 | ||||||||
|
1,214 | 1,201 | ||||||||||
|
848 | 854 | ||||||||||
|
955 | 879 | ||||||||||
Total Oral, Personal and Home Care | 3,781 | 3,658 | ||||||||||
Pet Nutrition | 534 | 542 | ||||||||||
Total Net sales | $ | 4,315 |
$ |
4,200 | ||||||||
Three Months Ended |
||||||||||||
2013 |
2012 | |||||||||||
Operating profit | ||||||||||||
Oral, Personal and Home Care | ||||||||||||
|
$ | 215 | $ | 177 | ||||||||
|
312 | 350 | ||||||||||
|
200 | 183 | ||||||||||
|
248 | 220 | ||||||||||
Total Oral, Personal and Home Care | 975 | 930 | ||||||||||
Pet Nutrition | 136 | 148 | ||||||||||
Corporate(1) | (369 | ) | (140 | ) | ||||||||
Total Operating profit | $ | 742 | $ | 938 |
Note: |
||
(1) | Corporate operations include costs related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. | |
For the three months ended |
||
For the three months ended |
||
Table 5 | |||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
Geographic Sales Analysis Percentage Changes | |||||||||||||||||||||||||||||
For the Three Months Ended |
|||||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||||
COMPONENTS OF SALES CHANGE | |||||||||||||||||||||||||||||
Pricing | |||||||||||||||||||||||||||||
Coupons | |||||||||||||||||||||||||||||
Sales | Consumer & | ||||||||||||||||||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | |||||||||||||||||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Volume |
Incentives |
Exchange |
||||||||||||||||||||||
|
2.5 | % | 6.0 | % | 4.0 | % | 4.5 | % | 4.5 | % | 1.5 | % | (3.0 | )% | |||||||||||||||
|
(0.5 | )% | 0.5 | % | - |
|
0.5 | % | 0.5 | % | - |
|
(0.5 | )% | |||||||||||||||
|
1.0 | % | 9.0 | % | 5.5 | % | 6.0 | % | 6.0 | % | 3.0 | % | (7.5 | )% | |||||||||||||||
|
8.5 | % | 10.0 | % | 11.0 | % | 11.0 | % | 11.0 | % | (1.0 | )% | (1.5 | )% | |||||||||||||||
|
3.0 | % | 7.0 | % | 5.5 | % | 6.0 | % | 6.0 | % | 1.0 | % | (3.5 | )% | |||||||||||||||
|
5.5 | % | 5.5 | % | 3.5 | % | 3.5 | % | 3.5 | % | 2.0 | % | - |
|
|||||||||||||||
Total CP Products | 3.5 | % | 6.5 | % | 5.5 | % | 5.5 | % | 5.5 | % | 1.0 | % | (3.0 | )% | |||||||||||||||
Hill's | (1.5 | )% | 0.5 | % | (3.0 | )% | (3.0 | )% | (3.0 | )% | 3.5 | % | (2.0 | )% | |||||||||||||||
Emerging Markets (1) | 4.0 | % | 9.5 | % | 7.5 | % | 8.0 | % | 8.0 | % | 1.5 | % | (5.0 | )% | |||||||||||||||
Developed Markets | 1.0 | % | 2.0 | % | 0.5 | % | 0.5 | % | 0.5 | % | 1.5 | % | (1.0 | )% | |||||||||||||||
Notes: |
(1) Emerging Markets include |
Table 6 | |||||||||||||||||
|
|||||||||||||||||
Non-GAAP Reconciliations |
|||||||||||||||||
For the Three Months Ended |
|||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
|||||||||||||||||
Gross Profit | 2013 | 2012 | |||||||||||||||
Gross profit, GAAP | $ | 2,515 | $ | 2,437 | |||||||||||||
2012 Restructuring Program | 8 | - | |||||||||||||||
Costs related to the sale of land in |
4 | 7 | |||||||||||||||
Business realignment and other cost-saving initiatives | - | 2 | |||||||||||||||
Gross profit, non-GAAP | $ | 2,527 | $ | 2,446 | |||||||||||||
|
|||||||||||||||||
Gross Profit Margin | 2013 | 2012 | Change | ||||||||||||||
Gross profit margin, GAAP | 58.3 | % | 58.0 | % | 30 | ||||||||||||
2012 Restructuring Program | 0.2 | % | - | ||||||||||||||
Costs related to the sale of land in |
0.1 | % | 0.2 | % | |||||||||||||
Business realignment and other cost-saving initiatives | - | - | |||||||||||||||
Gross profit margin, non-GAAP | 58.6 | % | 58.2 | % | 40 | ||||||||||||
Selling, General and Administrative Expenses | 2013 | 2012 | |||||||||||||||
Selling, general and administrative expenses, GAAP | $ | 1,536 | $ | 1,478 | |||||||||||||
2012 Restructuring Program | (8 | ) | - | ||||||||||||||
Business realignment and other cost-saving initiatives | - | (7 | ) | ||||||||||||||
Selling, general and administrative expenses, non-GAAP | $ | 1,528 | $ | 1,471 | |||||||||||||
|
|||||||||||||||||
Selling, General and Administrative Expenses as a Percentage of Net Sales | 2013 | 2012 | Change | ||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 35.6 | % | 35.2 | % | 40 | ||||||||||||
2012 Restructuring Program | (0.2 | )% | - | ||||||||||||||
Business realignment and other cost-saving initiatives | - | (0.2 | )% | ||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 35.4 | % | 35.0 | % | 40 | ||||||||||||
Other (Income) Expense, Net | 2013 | 2012 | |||||||||||||||
Other (income) expense, net, GAAP | $ | 237 | $ | 21 | |||||||||||||
2012 Restructuring Program | (50 | ) | - | ||||||||||||||
|
(172 | ) | - | ||||||||||||||
Costs related to the sale of land in |
(1 | ) | - | ||||||||||||||
Business realignment and other cost-saving initiatives | - | 4 | |||||||||||||||
Other (income) expense, net, non-GAAP | $ | 14 | $ | 25 | |||||||||||||
Operating Profit | 2013 | 2012 | % Change | ||||||||||||||
Operating profit, GAAP | $ | 742 | $ | 938 | (21 | )% | |||||||||||
2012 Restructuring Program | 66 | - | |||||||||||||||
|
172 | - | |||||||||||||||
Costs related to the sale of land in |
5 | 7 | |||||||||||||||
Business realignment and other cost-saving initiatives | - | 5 | |||||||||||||||
Operating profit, non-GAAP | $ | 985 | $ | 950 | 4 | % | |||||||||||
|
|||||||||||||||||
Operating Profit Margin | 2013 | 2012 | Change | ||||||||||||||
Operating profit margin, GAAP | 17.2 | % | 22.3 | % | (510 | ) | |||||||||||
2012 Restructuring Program | 1.5 | % | - | ||||||||||||||
|
4.0 | % | - | ||||||||||||||
Costs related to the sale of land in |
0.1 | % | 0.2 | % | |||||||||||||
Business realignment and other cost-saving initiatives | - | 0.1 | % | ||||||||||||||
Operating profit margin, non-GAAP | 22.8 | % | 22.6 | % | 20 | ||||||||||||
Net Income Attributable to |
2013 | 2012 | % Change | ||||||||||||||
Net income attributable to |
$ | 460 | $ | 593 | (22 | )% | |||||||||||
2012 Restructuring Program | 52 | - | |||||||||||||||
|
111 | - | |||||||||||||||
Costs related to the sale of land in |
3 | 5 | |||||||||||||||
Business realignment and other cost-saving initiatives | - | 3 | |||||||||||||||
Net income attributable to |
$ | 626 | $ | 601 | 4 | % | |||||||||||
Earnings Per Common Share, Diluted (1) | 2013 | 2012 | % Change | ||||||||||||||
Earnings per common share, diluted, GAAP | $ | 0.97 | $ | 1.23 | (21 | )% | |||||||||||
2012 Restructuring Program | 0.11 | - | |||||||||||||||
|
0.23 | - | |||||||||||||||
Costs related to the sale of land in |
0.01 | 0.01 | |||||||||||||||
Business realignment and other cost-saving initiatives | - | - | |||||||||||||||
Earnings per common share, diluted, non-GAAP | $ | 1.32 | $ | 1.24 | 6 | % | |||||||||||
(1) The impact of non-GAAP adjustments on the diluted earnings per share may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding. |
or
Source:
News Provided by Acquire Media